RAGONESE, Marta
 Distribuzione geografica
Continente #
EU - Europa 3.259
NA - Nord America 2.330
AS - Asia 1.489
SA - Sud America 482
AF - Africa 54
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.617
Nazione #
US - Stati Uniti d'America 2.267
RU - Federazione Russa 1.862
SG - Singapore 597
CN - Cina 441
BR - Brasile 419
IE - Irlanda 306
SE - Svezia 276
IT - Italia 254
HK - Hong Kong 162
DE - Germania 127
FR - Francia 95
GB - Regno Unito 93
VN - Vietnam 77
PL - Polonia 71
FI - Finlandia 54
IN - India 46
UA - Ucraina 34
BD - Bangladesh 26
CA - Canada 26
JP - Giappone 25
AR - Argentina 24
AT - Austria 24
MX - Messico 24
IQ - Iraq 23
NL - Olanda 18
ID - Indonesia 15
TR - Turchia 15
ZA - Sudafrica 15
CO - Colombia 13
PK - Pakistan 11
ES - Italia 10
KE - Kenya 8
MA - Marocco 7
PE - Perù 7
UZ - Uzbekistan 7
VE - Venezuela 7
BE - Belgio 6
MY - Malesia 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
CI - Costa d'Avorio 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
EC - Ecuador 4
JM - Giamaica 4
JO - Giordania 4
TN - Tunisia 4
AL - Albania 3
EE - Estonia 3
IL - Israele 3
KG - Kirghizistan 3
LT - Lituania 3
MD - Moldavia 3
NP - Nepal 3
PS - Palestinian Territory 3
RS - Serbia 3
SN - Senegal 3
UY - Uruguay 3
BH - Bahrain 2
CG - Congo 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
LK - Sri Lanka 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
AZ - Azerbaigian 1
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
EG - Egitto 1
GA - Gabon 1
GF - Guiana Francese 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
MG - Madagascar 1
MK - Macedonia 1
NO - Norvegia 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.617
Città #
Ashburn 503
Moscow 483
Singapore 325
Dublin 305
Dallas 240
Chandler 194
Nyköping 173
Hong Kong 159
San Jose 156
Beijing 152
Messina 112
The Dalles 103
Jacksonville 75
Los Angeles 69
Warsaw 69
Munich 67
New York 59
Lauterbourg 47
Princeton 43
Medford 42
São Paulo 41
Lancaster 40
Dearborn 35
Cambridge 29
Tianjin 27
Des Moines 26
Buffalo 24
Council Bluffs 22
Orem 20
Brooklyn 19
Ho Chi Minh City 19
Santa Clara 19
Tokyo 19
Vienna 19
Ann Arbor 18
Frankfurt am Main 18
Redondo Beach 18
Shenyang 18
Boardman 17
Helsinki 17
Hanoi 15
Seattle 14
London 13
Guangzhou 12
Wilmington 12
Baghdad 11
Jinan 11
Nanjing 11
Rio de Janeiro 11
Belo Horizonte 10
Brasília 10
Denver 10
Hyderabad 10
Pune 10
Shenzhen 10
Amsterdam 9
Catania 9
Johannesburg 9
Mexico City 9
Rome 9
Jakarta 8
Manchester 8
Nairobi 8
Nanchang 8
San Mateo 8
Turku 8
Bogotá 7
Chennai 7
Chicago 7
Düsseldorf 7
Montreal 7
Nuremberg 7
Stockholm 7
Tashkent 7
Toronto 7
Boston 6
Campinas 6
Curitiba 6
Dong Ket 6
Haikou 6
Hangzhou 6
Lappeenranta 6
Woodbridge 6
Atlanta 5
Biên Hòa 5
Changsha 5
Faisalabad 5
Hillsboro 5
Joinville 5
Lima 5
Milan 5
Mumbai 5
Phoenix 5
Poplar 5
Shanghai 5
São Gonçalo 5
São José do Rio Preto 5
Abidjan 4
Ankara 4
Aracaju 4
Totale 4.297
Nome #
Acromegaly is more severe in patients with AHR or AIP gene variants living in highly polluted areas 247
Cardiovascular events in acromegaly: distinct role of Agatston and Framingham score in the 5-year prediction. 204
Cyberknife stereotactic treatment of pituitary adenomas: A single center experience using different irradiation schemes and modalities 203
A case of clinically silent acromegaly with erectile dysfunction. 196
Global Cushing's disease epidemiology: a systematic review and meta-analysis of observational studies 191
Effects of cyberknife radiotherapy treatment of pituitary adenomas 182
Course of Pregnancy in Cushing Disease under Different Management Approaches (No Treatment, Surgery, Gamma-Knife or Ketoconazole) 179
P-57 Increased prevalence of acromegaly in an industrialized area of north-east of Sicily: a case-control study 177
Effectiveness and safety of long-term pegvisomant administration in patients with acromegaly not controlled by other therapies: experience of an Italian center. 176
Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study 175
Increased prevalence of acromegaly in a highly polluted area. 174
Dioxin-like pentachlorobiphenyls promote extra-cellular matrix remodeling by increasing the expression of endothelial cell-specific molecule 1 and metalloproteinases, and induce epigenetic modifications in thyrocytes 169
Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL. 166
GSTP1 gene methylation and AHR rs2066853 variant predict resistance to first generation somatostatin analogs in patients with acromegaly 164
Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas 163
Course of pregnancies in women with Cushing's disease treated by gamma-knife 162
Increased frequency of the rs2066853 variant of aryl hydrocarbon receptor gene in patients with acromegaly 162
Epidemiologia degli adenomi ipofisari nel nord-est della Sicilia 157
Predictive markers of recurrence in radically resected pituitary macroadenomas 157
Association between pain, arthropathy and health-related quality of life in patients suffering from acromegaly. A cross-sectional study 156
HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. 155
Cardiometabolic Risk in Acromegaly: A Review With a Focus on Pasireotide 154
MTHFR C677T polymorphism, folate status and colon cancer risk in acromegalic patients. 151
Resistance to somatostatin analogues is associated with GSTP1 gene methylation and AHR rs2066853 variant in acromegaly patients 150
MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior 150
Dissociated responsiveness of a growth hormone- and thyrotropin-secreting pituitary adenoma to octreotide-long-acting release therapy: The intriguing case of Mister B. 149
Preconception Thyrotropin Levels and Thyroid Function at Early Gestation in Women with Hashimoto's Thyroiditis 147
Subcutaneous lipoatrophy induced by long-term pegvisomant administration in a patient with acromegaly. 146
Thyroid nodules in growth hormone replaced patients. 145
First report on persistent remission of acromegaly after withdrawal of long-term pegvisomant monotherapy 143
How to improve effectiveness of pegvisomant treatment in acromegalic patients 140
Environmental Endocrinology and Endocrine Disruptors: Environmental Impact on the Hypothalamus–Pituitary Axis 138
Increased serum brain natriuretic peptide levels are a major predictor of myocardial hypertrophy in acromegalic patients. 134
Effects Of Epigenetic Changes In Gstp1 And Mgmt Gene On Clinicopathological Fatures Of Acromegaly Patients 134
Genetic and epigenetic modulation of AHR pathway in GH-secreting pituitary tumors and effects on acromegaly clinical phenotype 132
Epidemiology, course, and outcomes of Sars-CoV-2 infection in patients with acromegaly and Cushing’s disease: a monocentric experience in Southern Italy 131
Global psychological assessment with the evaluation of life and sleep quality and sexual and cognitive function in a large number of patients with acromegaly: a cross-sectional study 130
Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients 126
Trabecular bone score, bone marrow fat and vertebral fractures in cushing syndrome 108
Somatic Deletion in Exon 10 of Aryl Hydrocarbon Receptor Gene in Human GH-Secreting Pituitary Tumors 104
Long-Term Influence of Locus of Control and Quality of Life on Metabolic Profile in Elderly Subjects with Type 2 Diabetes 103
Subcutaneous lipoatrophy induced by long-term pegvisomant administration in a patient with acromegaly. 98
Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016 94
Are there country-specific differences in the use of pegvisomant for acromegaly in clinical practice? An analysis from ACROSTUDY 93
How to diagnose and manage Cushing's disease during pregnancy, when hypercortisolism is mild? 93
Imaging in endocrinologia: descrizione di un caso di cardiopatia acromegalica e fibrosi miocardica dimostrata in vivo mediante RMN 92
Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life 91
Valutazione della morfologia e funzionalità tiroidea in pazienti acromegalici 90
Development and testing of diagnostic algorithms to identify patients with acromegaly in Southern Italian claims databases 87
Endocrine disruptors, aryl hydrocarbon receptor and cortisol secretion 86
What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study 82
Should aip gene screening be recommended in family members of FIPA patients with R16H variant? 80
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patients 80
Chromatin conformation capture in the clinic: 4C-seq/HiC distinguishes pathogenic from neutral duplications at the GPR101 locus 78
Polychlorinated biphenyls (PCBs) modulate AHR pathways leading to the altered expression of genes involved in extra-cellular matrix (ECM) remodeling and epigenetic regulation in thyrocytes 76
null 35
Serum NT-pro-BNP Levels Predict Cardiovascular Events in Acromegaly Patients 31
null 27
Factors associated with disease control failure in acromegaly patients treated with pegvisomant: an ACROSTUDY analysis 22
Adverse hepato-biliary-pancreatic events in acromegaly patients treated with first generation somatostatin receptor ligands 8
Progression of acromegalic joint and psychological complications according to sex, treatments, and disease control 5
Totale 7.778
Categoria #
all - tutte 24.333
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.333


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 0 0 0 0 0 0 0 0 0 12
2021/2022305 0 58 5 13 7 5 9 17 3 52 38 98
2022/2023865 81 87 47 48 44 82 31 27 358 8 43 9
2023/2024292 20 44 15 28 29 70 9 29 0 13 2 33
2024/20251.403 21 32 57 83 99 43 47 276 293 98 132 222
2025/20264.224 224 241 282 252 362 917 514 559 548 179 74 72
Totale 7.778